CD4 and pneumonia: Furthermore, in the pneumonia model infected with the colistin-susceptible AbCS01 strain, both sulbactam therapy and treatment with memory CD4+ T and B cells increased survival rates compared with the untreated control animals (+80%, +70%, and +80%, p < 0.05) (Table 1 and Figure 2A).